Milrinone

Drug Status in USA : Approved
Drug Status in Canada : Approved

Indication : Why is this medication prescribed?

Short-term management of CCF in patients unresponsive to digitalis, diuretics or vasodilators.

Contraindication: What are the special precautions to be followed?

Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity. Heart valve stenosis, acute myocardial infarction.

Other Precaution to be observed while taking this medication

Monitor fluid and electrolyte balance. Do not use in patients with severe obstructive aortic or pulmonic valvular disease. Hypertrophic cardiomyopathy, atrial flutter or fibrillation. Pregnancy and lactation.

What are possible side effects of this medication ?

Headache, hypokalaemia, tremors, ventricular arrhythmias (including ventricular ectopic activity, hypotension nonsustained/sustained ventricular tachycardia, angina, ventricular fibrillation.)

Drug Category/Class

  • Platelet Aggregation Inhibitors
  • Phosphodiesterase Inhibitors
  • Cardiotonic Agents
  • Phosphodiesterase 3 Inhibitors
  • Vasodilator Agents
  • Cardiovascular System
  • Cardiac Therapy
  • Cardiac Stimulants Excl. Cardiac Glycosides
  • Phosphodiesterase inhibitors
Prescribed Indicated for the treatment of congestive heart failure.
Weight :211.2194
Structure Milrinone
Generic Drug Milrinone prescribed Indicated for the treatment of congestive heart failure.
Formula

C12H9N3O

Milrinone has 6 Brands listed


Milicor (10 mg)Milrineon (10 mg)
Mirisol (10 mg)Myolong (10 mg)
Primacor (10 mg)Primacor IV (10 mg)

Search Generic Drugs alphabetically